PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 6, 2019Sunhwan'giOpen Access

Catheter Ablation for Brugada Syndrome

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with Brugada syndrome (BrS) and recurrent ventricular fibrillation

Design

Review

Key result

Catheter ablation, particularly targeting the epicardial substrate in the right ventricular outflow tract, has emerged as an effective therapy for preventing recurrent ventricular fibrillation in patients with Brugada syndrome.

Authors

ATAhmed Karim TalibANAkihiko Nogami

Discussion

Loading...

Member takes

Overview

May suggest VF-prevention options beyond reactive ICDs in BrS; leaves open whether such approaches merit prospective trials.

Structured PICO

P
Population
Patients with Brugada syndrome (BrS) and recurrent ventricular fibrillation
I
Intervention
Catheter ablation (epicardial substrate ablation)

Epicardial catheter ablation is an increasingly applicable and effective alternative therapy for managing recurrent ventricular fibrillation in Brugada syndrome.

Limitations

  • A major limitation to the trigger ablation approach is the rare occurrence of premature ventricular complexes in Brugada syndrome patients.
  • Achieving complete epicardial substrate elimination can be challenging.
  • Patients with early repolarization syndrome combined with Brugada ECG may remain at high risk of developing ventricular fibrillation after ablation.

Cite This Study

Talib et al. (2019) conducted a review in Brugada syndrome. Catheter ablation was evaluated. Catheter ablation, particularly targeting the epicardial substrate in the right ventricular outflow tract, has emerged as an effective therapy for preventing recurrent ventricular fibrillation in patients with Brugada syndrome.

synapsesocial.com/papers/6a7bc783a540d02696c29d1dhttps://doi.org/10.4070/kcj.2019.0344
View Full Paper
Ask AI
Bookmark
Share